OR WAIT 15 SECS
© 2020 MJH Life Sciences and BioPharm International. All rights reserved.
© 2020 MJH Life Sciences™ and BioPharm International. All rights reserved.
With globalization, biopharmaceutical companies must establish strategies to minimize vulnerabilities in the raw-materials supply chain.
As the complex requirements of manufacturing biologics are manifold, it is important that biomanufacturing companies adopt quality-by-design principles.
The authors present solutions based on a review of current service offerings and their audit experience.